Long-term outcomes of patients with giant cell arteritis enrolled in a clinical trial of methotrexate treatment

被引：0
|
作者：
Hernandez-Garcia, Cesar [1 ]
Quinoa, Inmaculada C. Morado [1 ]
Jover, Juan A. [1 ]
Fernandez-Gutierrez, Benjamin [1 ]
Macarron, Pilar [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [21] NO ADVANTAGE OF METHOTREXATE IN THE TREATMENT OF GIANT CELL ARTERITIS
    Monjo Henry, I.
    Coronel, Luis
    Castano, Ignacio
    Peiteado, Diana
    Garcia-Carazo, Sara
    Balsa, Alejandro
    de Miguel, Eugenio
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 435 - 436
  • [22] LONG-TERM OUTCOME OF TOCILIZUMAB FOR PATIENTS WITH GIANT CELL ARTERITIS: RESULTS FROM PART 2 OF THE GIACTA TRIAL
    Stone, John H.
    Bao, Min
    Han, Jian
    Aringer, Martin
    Blockmans, Daniel
    Brouwer, Elisabeth
    Cid, Maria C.
    Dasgupta, Bhaskar
    Rech, Juergen
    Salvarani, Carlo
    Spiera, Robert
    Unizony, Sebastian
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 145 - 146
  • [23] Long-term outcome of tocilizumab for patients with giant cell arteritis: Results from part 2 of the GiACTA trial
    Neumann, T.
    Stone, J. H.
    Bao, M.
    Han, J.
    Aringer, M.
    Blockmans, D.
    Brouwer, E.
    Cid, M. C.
    Dasgupta, B.
    Rech, J.
    Salvarani, C.
    Spiera, R.
    Unizony, S. H.
    SWISS MEDICAL WEEKLY, 2019, : 15S - 15S
  • [24] May Giant Cell Arteritis Be Characterized By Different Clinical Entity and Long-Term Outcome?
    Talarico, Rosaria
    Stagnaro, Chiara
    Ferrari, Claudia
    d'Ascanio, Anna
    Tani, Chiari
    Baldini, Chiara
    Mosca, Marta
    Bombardieri, Stefano
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S710 - S711
  • [25] Long Term Efficacy of Ustekinumab for the Treatment of Giant Cell Arteritis
    Conway, Richard
    O'Neill, Lorraine
    Gallagher, Phil
    O'Flynn, Eileen
    McCarthy, Geraldine M.
    Murphy, Conor
    Veale, Douglas J.
    Fearon, Ursula
    Molloy, Eamonn S.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [26] LONG-TERM AND BOOSTER VACCINATION RESPONSES IN PATIENTS WITH GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA
    Van Sleen, Y.
    Van der Geest, K.
    Buisman, A.
    Sandovici, M.
    Van Baarle, D.
    Brouwer, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1870 - 1870
  • [27] FREQUENCY OF RELAPSES AND TREATMENT DISCONTINUATION DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH GIANT CELL ARTERITIS
    Tsalapaki, C.
    Lazarini, A.
    Antonatou, K.
    Thomas, K.
    Klavdianou, K.
    Koutsianas, C.
    Vassilopoulos, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 321 - 321
  • [28] METHOTREXATE TREATMENT IN THE MANAGEMENT OF GIANT-CELL ARTERITIS
    HERNANDEZGARCIA, C
    SORIANO, C
    MORADO, C
    RAMOS, P
    GUTIERREZ, BF
    HERRERO, M
    BANARES, A
    JOVER, JA
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (06) : 295 - 298
  • [29] Long-term renal outcome of patients enrolled in the CYCAZAREM trial
    Berden, Annelies
    Casian, Alina
    Westman, Kerstin
    Bajema, Ingeborg
    Jayne, David
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 51 - 51
  • [30] Long-term outcomes of ultrasonic scalpel treatment in giant cell tumor of long bones
    Sun, Sheng
    Zhang, Qiang
    Zhao, Chang-Song
    Cai, Juan
    ONCOLOGY LETTERS, 2014, 8 (01) : 145 - 150
12345